My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension.

    Chiba T, Kashiwagi K, Chiba N, Tsukahara S.

    Br J Ophthalmol. 2006 Mar;90(3):314-7.PMID: 16488953 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.

    Kashiwagi K, Tsukahara S.

    Br J Ophthalmol. 2003 Mar;87(3):297-301.PMID: 12598441 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.

    Sponsel WE, Paris G, Trigo Y, Pena M, Weber A, Sanford K, McKinnon S.

    Am J Ophthalmol. 2002 Jan;133(1):11-8.PMID: 11755835 [PubMed - indexed for MEDLINE]Related articles

    4.

    A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.

    Clin Ther. 2006 Mar;28(3):332-9.PMID: 16750448 [PubMed - indexed for MEDLINE]Related articles

    5.

    The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.

    Costagliola C, Parmeggiani F, Antinozzi PP, Caccavale A, Cotticelli L, Sebastiani A.

    Exp Eye Res. 2005 Nov;81(5):610-5. Epub 2005 Jun 8.PMID: 15949795 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.

    Simmons ST, Samuelson TW.

    Clin Ther. 2000 Apr;22(4):388-99.PMID: 10823361 [PubMed - indexed for MEDLINE]Related articles

    7.

    24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

    Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM; Bimatoprost Circadian IOP Study Group.

    Surv Ophthalmol. 2004 Mar;49 Suppl 1:S26-35.PMID: 15016559 [PubMed - indexed for MEDLINE]Related articles

    8.

    The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.

    Diestelhorst M.

    Graefes Arch Clin Exp Ophthalmol. 2000 May;238(5):433-9.PMID: 10901475 [PubMed - indexed for MEDLINE]Related articles

    9.

    A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

    Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.

    Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90.PMID: 17415690 [PubMed - indexed for MEDLINE]Related articles

    10.

    A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.

    Maul E, Carrasco FG, Costa VP, Casiraghi JF, Vargas E, Sarmina JS, Mayol R.

    Clin Ther. 2007 Sep;29(9):1915-23.PMID: 18035191 [PubMed - indexed for MEDLINE]Related articles

    11.

    Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.

    Simmons ST, Earl ML; Alphagan/Xalatan Study Group.

    Ophthalmology. 2002 Feb;109(2):307-14; discussion 314-5.PMID: 11825814 [PubMed - indexed for MEDLINE]Related articles

    12.

    A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.

    DuBiner HB, Mroz M, Shapiro AM, Dirks MS; Brimonidine vs. Latanoprost Study Group.

    Clin Ther. 2001 Dec;23(12):1969-83.PMID: 11813932 [PubMed - indexed for MEDLINE]Related articles

    13.

    Latanoprost: experience of 2-year treatment in Scandinavia.

    Alm A, Widengård I.

    Acta Ophthalmol Scand. 2000 Feb;78(1):71-6.PMID: 10726794 [PubMed - indexed for MEDLINE]Related articles

    14.

    Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

    Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

    Am J Ophthalmol. 2001 Oct;132(4):472-84.PMID: 11589866 [PubMed - indexed for MEDLINE]Related articles

    15.

    Additive IOP-reducing effect of latanoprost in patients insufficiently controlled on timolol.

    Bron AM, Denis P, Nordmann JP, Rouland JF, Sellem E, Johansson M.

    Acta Ophthalmol Scand. 2001 Jun;79(3):289-93.PMID: 11401641 [PubMed - indexed for MEDLINE]Related articles

    16.

    A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

    Parrish RK, Palmberg P, Sheu WP; XLT Study Group.

    Am J Ophthalmol. 2003 May;135(5):688-703.PMID: 12719078 [PubMed - indexed for MEDLINE]Related articles

    17.

    A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

    Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

    Am J Ophthalmol. 2003 Jan;135(1):55-63.PMID: 12504698 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

    Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.

    Ann Pharmacother. 2008 Apr;42(4):498-504. Epub 2008 Mar 25.PMID: 18364402 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.

    Petounis A, Mylopoulos N, Kandarakis A, Andreanos D, Dimitrakoulias N.

    J Glaucoma. 2001 Aug;10(4):316-24.PMID: 11558817 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.

    DuBiner H, Cooke D, Dirks M, Stewart WC, VanDenburgh AM, Felix C.

    Surv Ophthalmol. 2001 May;45 Suppl 4:S353-60.PMID: 11434938 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity